GlassScriptPhysician profile
Ian Tafel
NPI 1205249596
$37,325.39
in general payments reported to CMS, 2019-2025
11 companies · $13K in 2025
The $13K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $304 · 2022: $935 · 2023: $12K · 2024: $10K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Food and Beverage: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,849.30 |
| Food and Beverage | $1,236.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spine Wave, INC. | $20,979.10 | 2022-2025 | Exceed Biplanar Expandable Interbody System, Spinal Implant, Salvo Spine System |
| Elevation Spine, INC. | $13,520.54 | 2023-2025 | |
| Expanding Innovations, INC. | $837.32 | 2025 | X-Pac |
| Zavation Medical Products, LLC | $750.00 | 2023 | |
| Medtronic, INC. | $602.49 | 2022 | |
| Spineology INC. | $235.32 | 2021-2022 | |
| Augmedics INC. | $208.21 | 2021 | |
| Biocomposites INC | $109.32 | 2025 | Stimulan |
| Nuvasive, INC. | $30.35 | 2022 | |
| Abbvie INC. | $28.41 | 2025 | |
| Integra Lifesciences Corporation | $24.33 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,198.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Tafel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.